InnaVirVax's Grant

InnaVirVax raised a round of funding on July 14, 2008. Investors include French National Research Agency.

InnaVirVax is a biopharmaceutical company researching and developing therapeutic and diagnostic solutions for diseases linked to the immune system. Through its research on immune dysregulations, the c…

Articles about InnaVirVax's Grant: